Antimutagenic 1,4-Dihydropyridine AV-153 Normalizes Expression of GLUT1, GLUT4, INOS, PARP1, and Gamma H2AX Histone in Myocardium of Rats with Streptozotocin Model of Diabetes Mellitus

Rostoka, Evita; Isajevs, Sergejs; Sokolovska, Jeļizaveta; Duburs, Gunārs; Sjakste, Nikolajs

doi:10.2478/prolas-2023-0014

Abstract

Diabetic cardiomyopathy increases the risk of heart failure and worsens prognosis for diabetes mellitus (DM) patients. Its development depends on many factors, including modification of nitric oxide production and impaired DNA repair. The goal of the present work was to study in vivo effects of a 1,4-dihydropyridine AV-153, known as antimutagen and DNA-binder, on DNA integrity, and on the expression of several proteins involved in glucose transport, nitric oxide metabolism, and DNA repair in myocardium in diabetic rats. DM was induced in rats by streptozotocin (STZ) injection. Expression of proteins was studied by means of immunohistochemistry. Development of the STZ-induced DM significantly induced PARP1 and gamma H2AX histone, markers of DNA breakage, protein expression in heart tissue, while AV-153 administration decreased PARP1 and H2AX protein expression. In this model of diabetes, myocardial expression of iNOS was also significantly increased, but administration of AV-153 reduced it to normal levels. AV-153 also upregulated the expression of insulin-dependent GLUT4 and insulin-independent GLUT1 glucose transporters up to normal level in diabetic rats. Thus, AV-153 appears to be prospective for creation of a remedy for prevention of diabetic cardiomyopathy.

References

Bagchi, R. A., Weeks, K. L. (2019). Histone deacetylases in cardiovascular and metabolic diseases. J. Mol. Cell. Cardiol., 130, 151–159.
Search in Google Scholar Back to article
Buraka, E., Chen, C. Y., Gavare, M., Grube, M., Makarenkova, G., Nikolajeva, V., Bisenieks, I., Brūvere, I., Bisenieks, E., Duburs, G., Sjakste, N. (2014). DNA-binding studies of AV-153, an antimutagenic and DNA repair-stimulating derivative of 1,4-dihydropiridine. Chem. Biol. Interact., 220, 200–207.
Search in Google Scholar Back to article
Chanda, D., Luiken, J. J. F. P., Glatz, J. F. C. (2016). Signalling pathways involved in cardiac energy metabolism. FEBS Lett., 590 (15), 2364–2374.
Search in Google Scholar Back to article
Chen, Y., Du, J., Zhao, Y. T., Zhang, L., Lv, G., Zhuang, S., Qin, G., Zhao, T. C. (2015). Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice. Cardiovasc. Diabetol., 14, 99.
Search in Google Scholar Back to article
Choi, S. Y., Jeong, H. J., Lim, H. G., Park, S. S., Kim, S. H., Kim, Y. J. (2012). Elimination of alpha-galxenoreactive epitope: alpha-galactosidase treatment of porcine heart valves. J. Heart. Valve Dis., 21, 387–397.
Search in Google Scholar Back to article
Dislere, K., Rostoka, E., Bisenieks, E., Duburs, G., Paramonova, N., Sjakste, N. (2021). 1,4-dihydropyridine derivatives increase mRNA expression of Psma3, Psmb5, and Psmc6 in rats. Arh. Hig. Rada Toksikol. 72, 148–156.
Search in Google Scholar Back to article
Faramoushi, M., Sasan, R. A., Sarraf, V. S., Karimi, P. (2016). Cardiac fibrosis and down regulation of GLUT4 in experimental diabetic cardiomyopathy are ameliorated by chronic exposures to intermittent altitude. J. Cardiovasc. Thorac. Res., 8 (1), 26–33.
Search in Google Scholar Back to article
Faria, A., Persaud, S. J. (2017). Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential. Pharmacol. Ther., 172, 50–62.
Search in Google Scholar Back to article
Forbes, J. M., Cooper, M. E. (2013). Mechanisms of diabetic complications. Physiol. Rev., 93, 137–188.
Search in Google Scholar Back to article
Gilca, G.E., Stefanescu, G., Badulescu, O., Tanase, D. M., Bararu, I., Ciocoiu, M. (2017). Diabetic cardiomyopathy: Current approach and potential diagnostic and therapeutic targets. J. Diabetes. Res., 2017, 1310265.
Search in Google Scholar Back to article
Henning, R. J., Bourgeois, M., Harbison, R. D. (2018). Poly(ADP-ribose) polymerase (PARP) and PARP inhibitors: Mechanisms of action and role in cardiovascular disorders. Cardiovasc. Toxicol., 18, 493–506.
Search in Google Scholar Back to article
Isfort, M., Stevens, S. C. W., Schaffer, S., Jong, C. J., Wold, L. E. (2014). Metabolic dysfunction in diabetic cardiomyopathy. Heart. Fail. Rev., 19, 35–48.
Search in Google Scholar Back to article
Ivanović-Matić, S., Bogojević, D., Martinović, V., Petrović, A., Jovanović-Stojanov, S., Poznanović, G., Grigorov, I. (2014). Catalase inhibition in diabetic rats potentiates DNA damage and apoptotic cell death setting the stage for cardiomyopathy. J. Physiol. Biochem., 70 (4), 947–959.
Search in Google Scholar Back to article
Khullar, M., Cheema, B. S., Raut, S. K. (2017). Emerging evidence of epigenetic modifications in vascular complication of diabetes. Front. Endocrinol. (Lausanne), 8, 237.
Search in Google Scholar Back to article
Leonova, E., Ošiņa, K., Duburs, G., Bisenieks, E., Germini, D., Vassetzky, Y., Sjakste, N. (2019). Metal ions modify DNA-protecting and mutagen-scavenging capacities of the AV-153 1,4-dihydropyridine. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 845, 403077.
Search in Google Scholar Back to article
Leonova, E., Rostoka, E., Sauvaigo, S., Baumane. L., Selga, T., Sjakste, N. (2018). Study of interaction of antimutagenic 1,4-dihydropyridine AV-153-Na with DNA-damaging molecules and its impact on DNA repair activity. PeerJ., 6, e4609.
Search in Google Scholar Back to article
Leonova, E., Shvirksts, K., Borisovs, V., Smelovs, E., Sokolovska, J., Bisenieks, E., Duburs, G., Grube, M., Sjakste, N. (2020). Spectroscopic and electrochemical study of interactions between DNA and different salts of 1,4-dihydropyridine AV-153. PeerJ, 8, e10061.
Search in Google Scholar Back to article
Maack, C., Lehrke, M., Backs, J., Heinzel, F. R., Hulot, J. S., Marx, N., Paulus, W. J., Rossignol, P., Taegtmeyer, H., et al. (2018). Heart failure and diabetes: Metabolic alterations and therapeutic interventions: A state-of-the-art review from the translational research committee of the heart failure association-European society of cardiology. Eur. Heart. J., 39 (48), 4243–4254.
Search in Google Scholar Back to article
Maria, Z., Campolo, A. R., Scherlag, B. J., Ritchey, J. W., Lacombe, V. A. (2018). Dysregulation of insulin-sensitive glucose transporters during insulin resistance-induced atrial fibrillation. Biochim. Biophys. Acta. Mol. Basis. Dis., 1864 (4 Pt A), 987–996.
Search in Google Scholar Back to article
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., Zuniga, F. A. (2018). Association between insulin resistance and the development of cardiovascular disease. Cardiovasc. Diabetol., 17 (1), 122.
Search in Google Scholar Back to article
Osina, K., Leonova, E., Isajevs, S., Baumane, L., Rostoka, E., Sjakste, T., Bisenieks, E., Duburs, G., Vigante, B., Sjakste, N. (2017). Modifications of expression of genes and proteins involved in DNA repair and nitric oxide metabolism by carbatonides [disodium-2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) derivatives] in intact and diabetic rats. Arh. Hig. Rada Toksikol. 68, 212–227.
Search in Google Scholar Back to article
Osina, K., Rostoka, E., Isajevs, S., Sokolovska, J., Sjakste, T., Sjakste, N. (2016). Effects of an antimutagenic 1,4-dihydropyridine AV-153 on expression of nitric oxide synthases and DNA repair-related enzymes and genes in kidneys of rats with a streptozotocin model of dabetes mellitus. Basic. Clin. Pharmacol. Toxicol., 119 (5), 458–463.
Search in Google Scholar Back to article
Ošiņa, K., Rostoka, E., Sokolovska, J., Paramonova, N., Bisenieks, E., Duburs, G., Sjakste, N., Sjakste, T. (2016). 1,4-Dihydropyridine derivatives without Ca2+-antagonist activity up-regulate Psma6 mRNA expression in kidneys of intact and diabetic rats. Cell Biochem. Funct. 34, 3–6.
Search in Google Scholar Back to article
Pepin, M. E., Wende, A. R. (2019). Epigenetics in the development of diabetic cardiomyopathy. Epigenomics., 11 (5), 469–472.
Search in Google Scholar Back to article
Qin, W. D., Liu, G. L., Wang, J., Wang, H., Zhang, J. N., Zhang, F., Ma, Y., Ji, X. Y., Li, C., Zhang, M. X. (2016). Poly (ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy. Oncotarget, 7 (24), 35618–35631.
Search in Google Scholar Back to article
Ryabokon, N. I., Goncharova, R. I., Duburs, G., Hancock, R., Rzeszowska-Wolny, J. (2008). Changes in poly(ADP-ribose) level modulate the kinetics of DNA strand break rejoining. Mutat. Res., 637, 173–181.
Search in Google Scholar Back to article
Ryabokon, N. I., Goncharova, R. I., Duburs, G., Rzeszowska-Wolny, J. (2005). A 1,4-dihydropyridine derivative reduces DNA damage and stimulates DNA repair in human cells in vitro. Mutat Res., 587 (1–2), 52–58.
Search in Google Scholar Back to article
Ryabokon, N. I., Nikitchenko, N. V., Dalivelya, O. V., Goncharova, R. I., Duburs, G., Konopacka, M., Rzeszowska-Wolny, J. (2009). Modulation of cellular defense processes in human lymphocytes in vitro by a 1,4-dihydropyridine derivative. Mutat. Res., 679 (1–2), 33–38.
Search in Google Scholar Back to article
Szablewski, L. (2017). Glucose transporters in healthy heart and in cardiac disease. Int J. Cardiol., 230, 70–75.
Search in Google Scholar Back to article
Varga, Z. V., Giricz, Z., Liaudet, L., Hasko, G., Ferdinandy, P., Pacher, P. (2015). Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim. Biophys. Acta, 1852 (2), 232–242.
Search in Google Scholar Back to article
von Lukowicz, T., Hassa, P. O., Lohmann, C., Borén, J., Braunersreuther, V., Mach, F., Odermatt, B., Gersbach, M., Camici, G. G., Stähli, B. E., et al. (2008). PARP1 is required for adhesion molecule expression in atherogenesis. Cardiovasc. Res. 78, 158–166.
Search in Google Scholar Back to article
Waldman, M., Nudelman, V., Shainberg, A., Abraham, N. G., Kornwoski, R., Aravot, D., Arad, M., Hochhauser, E. (2018). PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis. Exp. Cell. Res., 373 (1–2), 112–118.
Search in Google Scholar Back to article
Wang, J., Wang, S., Wang, J., Xiao, M., Guo, Y., Tang, Y., Zhang, J., Gu, J. (2021). Epigenetic regulation associated with sirtuin 1 in complications of diabetes mellitus. Frontiers Endocrinol., 11, 598012.
Search in Google Scholar Back to article

Antimutagenic 1,4-Dihydropyridine AV-153 Normalizes Expression of GLUT1, GLUT4, INOS, PARP1, and Gamma H2AX Histone in Myocardium of Rats with Streptozotocin Model of Diabetes Mellitus

Abstract

Paradigm

My account